These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 45392)

  • 1. Clinical experience with some beta blocking agents and their derivatives in endogenous depressions.
    Svestka J; Náhunek K; Cesková E
    Agressologie; 1979; 20(D):295-8. PubMed ID: 45392
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-adrenergic blocking drugs versus diazepam in the treatment of anxious-depressive syndrome.
    Kabes J; Dostal T
    Act Nerv Super (Praha); 1977 Jul; 19 Suppl 2():374-7. PubMed ID: 45167
    [No Abstract]   [Full Text] [Related]  

  • 3. Nadolol and antidepressant response.
    Faber R
    Biol Psychiatry; 1983 Nov; 18(11):1338-9. PubMed ID: 6140034
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience with the prolonged use of beta-adrenergic blocking agents in the ambulatory treatment of patients with ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1980; 52(8):99-103. PubMed ID: 6114576
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with bromazepam in endogenous depression].
    Náhunek K; Svestka J; Buresová A; Cesková E; Rysánek R; Novotná H
    Cesk Psychiatr; 1985 Aug; 81(4):235-41. PubMed ID: 2864140
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
    Shikara MM; Polena S; Solinas A; Sanghvi K; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():125-6. PubMed ID: 14699906
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
    Cirino D; Savonelli C; Maggi GC
    Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical characteristics and typological classification of endogenous depression resistant to treatment].
    Bondar' VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):84-8. PubMed ID: 1319660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auscultatory changes following ventricular extrasystoles and beta-blocking agents.
    Abinader EG
    Ir Med J; 1975 Aug; 68(15):369-75. PubMed ID: 52632
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study of levoprotiline and amitriptyline in endogenous depressions.
    Faltus F; Molcan J; Svestka J; Náhunek K; Mrna B; Zapletálek M; Krekule P; Janecková E; Koníková M; Pazdírek S
    Act Nerv Super (Praha); 1989 Dec; 31(4):279-80. PubMed ID: 2638109
    [No Abstract]   [Full Text] [Related]  

  • 11. Physician characteristics and the initiation of beta-adrenergic blocking agent therapy after acute myocardial infarction in a managed care population.
    Fehrenbach SN; Budnitz DS; Gazmararian JA; Krumholz HM
    Am J Manag Care; 2001 Jul; 7(7):717-23. PubMed ID: 11464429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of beta-adrenergic blocking agents in the therapy of cardiac arrhythmias].
    Streian C; Hodas C; Gavrilescu S
    Med Interna (Bucur); 1974 May; 26(5):583-92. PubMed ID: 4152240
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with treatment of depressions by nomiphenzine (author's transl)].
    Pogády J; Vencovský E; Zizka V
    Cesk Psychiatr; 1981 Feb; 77(1):11-6. PubMed ID: 7018709
    [No Abstract]   [Full Text] [Related]  

  • 14. [Beta blocking agents in arterial hypertension: 20-year experience].
    Casiglia E; Gava R; Giacomello M; Falliero E; Cima L; Giusti P
    Clin Ter; 1988 Jan; 124(1):3-16. PubMed ID: 2904319
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of endogenous depressions with valpromide (open study).
    Svestka J; Rysánek R; Cesková E
    Homeost Health Dis; 1991; 33(5-6):291-2. PubMed ID: 18265503
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of severe hypertension with nifedipine associated with beta-blocking agents (author's transl)].
    Plaza de los Reyes M; Passalacqua W; Saffie A; Plaza de los Reyes X
    Rev Med Chil; 1981 Feb; 109(2):125-9. PubMed ID: 6115461
    [No Abstract]   [Full Text] [Related]  

  • 17. The therapeutic effect of Trazodon with endogenous depressions.
    Peterova E; Vencovsky E
    Agressologie; 1981 Nov; 22(E):25. PubMed ID: 7332045
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical examination of the beta-adrenergic receptor blocking activity of Tobanum in spontaneously occurring anginas.
    Sipos Z; Hollósi Z; Iskum M
    Ther Hung; 1984; 32(2):74-8. PubMed ID: 6152819
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-arrhythmic effect of a new adrenergic beta receptor blocking substance].
    Rodrigues R; Kornfeld J; Pereira EM
    Arq Bras Cardiol; 1972 Dec; 25(6):471-5. PubMed ID: 4145022
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of endogenous depressions with maprotiline, clomipramine, dibenzepine and pyrlindole (author's transl)].
    Zapletálek M; Zbytovský J; Libiger J; Pazdírek S; Cápová E
    Cesk Psychiatr; 1981 Jun; 77(3):198-203. PubMed ID: 6119162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.